Cost-Minimization Analysis Of Rivaroxaban In Comparison To Enoxaparin Plus Warfarin For The Treatment Of Venous Thromboembolism (Vte) Under The Private Healthcare System Perspective
Abstract
Authors
A Piedade L Paladini F Tobaruella C Nakada